EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Neurofilament light chain as a potential mediator of the longitudinal association between depressive symptoms and cognitive aging

Ted K S Ng, Kyle R Dennis, Todd Beck, Jerenda Bond, Kristin R Krueger, Pankaja Desai, Robert S Wilson, Denis A Evans, Kumar B Rajan

Brain, Behavior, & Immunity - Health · 2026-12 · 58 · 101398

DOI: 10.1016/j.bbih.2026.101398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, & Immunity - Health, 2026-12. Verfasst von Ted K S Ng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Rush Institute for Healthy Aging, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depressive symptoms have long been associated with cognitive decline (CD) and Alzheimer's disease (AD), yet the biological processes connecting affective distress to later cognitive vulnerability remain poorly understood. Serum neurofilament light chain (NfL) is a circulating marker of neuroaxonal injury. We tested whether serum neurofilament light chain (NfL), a sensitive marker of neuroaxonal degeneration and an emerging biomarker in late-life depression, mediates the prospective association between depressive symptoms and subsequent adverse cognitive outcomes. We analyzed 921 Black and White community-dwelling older adults from the Chicago Health and Aging Project (CHAP; 1993-2012) with baseline depressive symptom scores (T1), serum NfL measured at the next wave (T2), and global cognition assessed across three waves (T1-T3; mean interval 6.34 years), with cognition at T3 serving as the primary outcome in the mediation analyses. A subsample of 445 participants had clinically adjudicated incident AD at T3 (79 AD cases). Mixed-effects models examined the association between baseline depressive symptoms and CD, followed by longitudinal mediation models using a temporally ordered T1→T2→T3 framework with 1000 simulations. Sensitivity analyses excluded baseline AD to assess model robustness. In mixed-effects models, higher baseline depressive symptoms were associated with accelerated CD in Models 1-2, with similar but nonsignificant associations after full adjustment (Model 3: β = -0.0041; p = 0.0581) and additional adjustment for NfL (Model 4: β = -0.0040; p = 0.0647). Mediation analyses identified significant indirect pathways through NfL linking depressive symptoms with poorer subsequent cognitive performance (indirect effect: -0.0046; 95% CI: -0.0089 to -0.0014; p = 0.004; 18.05% mediated) and accelerated CD (indirect effect: -0.0010; 95% CI: -0.0021 to -0.0002; p = 0.008; 10.49% mediated). Findings were robust to the exclusion of baseline AD. In the subsample with clinical AD diagnoses, NfL also mediated the prospective association between depressive symptoms and incident AD (indirect effect: 0.0033; 95% CI: 0.0000 to 0.0073; p = 0.046; 16.15% mediated), with attenuated significance in fully adjusted models consistent with the smaller sample and limited number of incident AD cases. These findings provide longitudinal evidence that depressive symptoms are associated with adverse cognitive outcomes, with indirect pathways through NfL accounting for part of these associations. These temporally ordered associations suggest that NfL may index a potential neurobiological pathway linking depressive symptoms with cognitive aging NfL may represent a biologically grounded marker for early risk detection and intervention in late-life depressive symptoms with implications for cognitive decline.

Schlagwörter

Stichwörter der Autor:innen

Axonal injuryCognitive declineDementiaDepressionNeurofilament lightStress biology

Autor:innen und Institutionen

  • Rush Institute for Healthy Aging, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
  • Rush Alzheimer's Disease Center, Department of Neurological Sciences, Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.

Förderung

  • NIA NIH HHS
  • National Institutes of Health

Zitieren

APA

Ng, T. K. S., Dennis, K. R., Beck, T., Bond, J., Krueger, K. R., Desai, P., Wilson, R. S., Evans, D. A., & Rajan, K. B. (2026). Neurofilament light chain as a potential mediator of the longitudinal association between depressive symptoms and cognitive aging. Brain, Behavior, & Immunity - Health, 58, 101398. https://doi.org/10.1016/j.bbih.2026.101398

Vancouver

Ng TKS, Dennis KR, Beck T, Bond J, Krueger KR, Desai P, et al. Neurofilament light chain as a potential mediator of the longitudinal association between depressive symptoms and cognitive aging. Brain, Behavior, & Immunity - Health. 2026;58:101398. doi:10.1016/j.bbih.2026.101398

BibTeX
@article{Ng2026,
  author = {Ng, Ted K S and Dennis, Kyle R and Beck, Todd and Bond, Jerenda and Krueger, Kristin R and Desai, Pankaja and Wilson, Robert S and Evans, Denis A and Rajan, Kumar B},
  title = {Neurofilament light chain as a potential mediator of the longitudinal association between depressive symptoms and cognitive aging},
  journal = {Brain, Behavior, & Immunity - Health},
  year = {2026},
  volume = {58},
  pages = {101398},
  doi = {10.1016/j.bbih.2026.101398}
}
Kostenlos starten →